Concepedia

Author

Dorie Sher

University of Chicago

Also Known As

D Sher, D. L. Sher, D. Sher, Dorie Sher

34

Publications

1.3K

Citations

14

H-Index

31

Concepts

All Affiliations

University of ChicagoUniversity of Illinois ChicagoThe Ohio State UniversityUniversity of Chicago Medical CenterLeukemia Research Foundation
DS

About

Dorie Sher is an author at University of Chicago specializing in medicine, immunology, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

675

2

Engineering

2

2

457

3

Health Sciences

1

1

10

4

Allergy

1

1

15

5

Biomedical Engineering

1

1

429

Dorie Sher

×

18

Publications

1.2K

Citations

14

H-Index

YearCitations

Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion

Steven M. Devine, Amelia Bartholomew, Nadim Mahmud,

Experimental Hematology

2001

429

Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease

Koen van Besien, Amelia Bartholomew, Wendy Stock,

Bone Marrow Transplantation

2000

98

The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-alpha receptors.

Shahab Uddin, Eleanor N. Fish, Dorie Sher,

PubMed

1997

97

Granulocyte-macrophage colony-stimulating factor (GM-CSF)–secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)

Ivan Borrello, Hyam I. Levitsky, Wendy Stock,

Blood

2009

97

Brusatol-mediated induction of leukemic cell differentiation and G1 arrest is associated with down-regulation of c-myc

Eugenia Mata‐Greenwood, Muriel Cuendet, Dorie Sher,

Leukemia

2002

83

Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909

Hui Liu, Jeffrey L. Johnson, Greg Koval,

Haematologica

2011

77

Histone Deacetylase Inhibitor Romidepsin Has Differential Activity in Core Binding Factor Acute Myeloid Leukemia

Olatoyosi Odenike, Serhan Alkan, Dorie Sher,

Clinical Cancer Research

2008

66

Alemtuzumab can be Incorporated Into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Phase I Results of a Cancer and Leukemia Group B Study (CALGB 10102).

Wendy Stock, Ben L. Sanford, Gerard Lozanski,

Blood

2009

64

Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of <i>FLT3</i> mutations and complex karyotype

Xavier Poiré, Barry Kurt Moser, Robert E. Gallagher,

Leukemia & lymphoma/Leukemia and lymphoma

2013

59

Phase II Trial of Low Dose, Subcutaneous Decitabine in Myelofibrosis

Olatoyosi Odenike, John E. Godwin, Koen van Besien,

Blood

2008

32

Page 1